Voss Capital, LP

13F Holdings History for Rein Therapeutics, Inc. - Common Stock, $0.001 par value (RNTX)

Symbol: RNTX on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Ownership: 2.67M shares
Security Ownership: 11.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Voss Capital, LP ownership in Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX)

2025-09-26 - Voss Capital, LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.67M shares of Rein Therapeutics, Inc. Common Stock, $0.001 par value (RNTX). This represents 11.3% percent ownership of the company. In their previous filing dated 2025-05-14, Voss Capital, LP had reported owning 1.28M shares, indicating an increase of 109% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Voss Capital, LP	11.3%	+95%	$3.73M	2.67M	+1,388,676	+109%	$1.40	13G/A	9/24/2025	26 Sep 2025 18:46:52
Voss Capital, LP	5.6%		$2.1M	1.28M			$1.64	13G	5/8/2025	14 May 2025 20:26:02

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.18%	+0.08%	$3.05M	2.67M	+1,232,846	+86%	$1.15	Q3 2025
6/30/2025	0.14%	+0.04%	$2.01M	1.43M	+442,970	+44.7%	$1.40	Q2 2025
3/31/2025	0.13%	+0%	$1.75M	991K	+34,521		$1.77	Q1 2025
12/31/2024	0.16%	+0.16%	$2.2M	956K	+956,195	NEW	$2.30	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.